Upon activation by VEGF, which is the ligand of VEGFR2, VEGFR2 appears to promote the formation of new blood vessels in its neighboring tissues, thereby facilitating the delivery of growth factors, nutrients, and oxygen for the proliferation, migration, metastasis, and survival of cancer cells. This evidence concerns the gene KDR and cancer.